Sunshine Biopharma, Inc.
SBFM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$1,771 | -$1,180 | -$2,158 |
| Dep. & Amort. | – | $73 | $65 | $65 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | -$637 | -$599 | $938 |
| Other Non-Cash | – | $1,062 | $0 | -$2,252 |
| Operating Cash Flow | – | -$1,273 | -$1,714 | -$3,407 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$160 | -$7 | -$444 |
| Net Acquisitions | – | $0 | $0 | -$92 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$332 | -$169 | $5 |
| Investing Cash Flow | – | -$492 | -$176 | -$532 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$58 | -$17 | $436 |
| Stock Issued | – | $1,829 | $355 | $1,618 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $1,840 | $0 | $0 |
| Financing Cash Flow | – | $3,610 | $338 | $2,054 |
| Forex Effect | – | $336 | -$10 | -$635 |
| Net Chg. in Cash | – | $2,181 | -$1,562 | -$2,520 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $8,125 | $9,687 | $12,207 |
| End Cash | – | $10,305 | $8,125 | $9,687 |
| Free Cash Flow | – | -$1,824 | -$1,926 | -$3,847 |